Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis

International Journal of Oral and Maxillofacial Surgery

Volumn 37, Issue 2, 2008, Pages 135-139

  Penel, N ^a,b   Lefebvre, J L ^a   Cazin, J L ^a   Clisant, S ^a   Neu, J C ^a   Dervaux, B ^c   Yazdanpanah, Y ^b,d  

^a CENTRE OSCAR LAMBRET   (France)

^b UNIV LILLE   (France)

^c CRESGE   (France)

^d Service Universitaire des Maladies Infectieuses et du Voyageur   (France)

Author keywords

cost; head and neck cancer; hospital stay; macrocosting; nosocomial infection; surgical site infection

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; SURGICAL INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COSTS AND COST ANALYSIS; CROSS INFECTION; DIRECT SERVICE COSTS; FEMALE; HEAD AND NECK NEOPLASMS; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 38949160441     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2007.08.002     Document Type: Article

References (28)

1. Agence Technique de l'Information sur l'Hospitalisation Echelle Nationale des coûts '2005' (données 2002-2003) http://www.atih.sante.fr/.
2. American Cancer Society. Cancer Facts and Figures 2005 (2005), American Cancer Society, Atlanta
3. Bonnema J., van Wersch A.M.E.A., van Geel A.N., Pruyn J.F.A., Schmitz P.I.M., Uyl-de Groot C.A., and Wiggers T. Cost of care in a randomised trial of early hospital discharge after surgery for breast cancer. Eur J Cancer 34 (1998) 2015-2020
4. Circulaire N°DHOS/F3/F1/2005/103 du 23 février 2005 relative à la campagne tarifaire 2005 pour les activités de médicine, chirurgie, obstétrique et odontologie exercées dans les établissements de Santé privés mentionnés aux d) et e) de l'article L 162-22-06 du code de sécurité sociale.
5. Coello R., Charlett A., Wilson J., Ward V., Pearson A., and Borriello P. Adverse impact of surgical site infections in English hospitals. J Hosp Infect 60 (2005) 93-103
6. Coskun D., Aytac J., Aydinli A., and Bayer A. Mortality rate, length of stay and extra-costs of sternal surgical infections following coronary bypass grating in a private medical centre in Turkey. J Hosp Infect 60 (2005) 176-179
7. Culver D.H., Horan T.C., Gaynes R.P., Martone W.J., Jarvis W.R., and Emori T. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med Suppl. 3B (1991) 152-157
8. Gianotti L., Braga M., Frei A., Greiner R., and Di Carlo V. Health care resources consumed to treat postoperative infections: cost saving by preoperative immunonutrition. Shock 14 (2000) 325-330
9. Harper D.R. Disease cost in a surgical ward. Br Med J 1 (1979) 647-649
10. Johnson J.T., Wagner R., Schuller D., Gluckman J., Suen J., and Snyderman N. Prophylactic antibiotics for head and neck surgery with flap reconstruction. Arch Otolaryngol Head Neck Surg 118 (1992) 488-490
11. Kambouris A. Physical, psychological, and economic advantages of accelerated discharge after surgical treatment for breast cancer. Am Surg 62 (1996) 123-127
12. Koopmanschap M.A., Van Roijen L., Bonneux L., and Barendergt J.J. Current and future costs of cancer. Eur J Cancer 30A (1994) 60-65
13. Morris J.A., and Gardner M.J. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J 296 (1988) 1313-1316
14. Penel N., Fournier C., Lefebvre D., and Lefebvre J.L. Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol 41 (2005) 294-303
15. Penel N., Lefebvre D., Fournier C., Sarini J., Kara A., and Lefebvre J.L. Risk factors for wound infection in head and neck cancer surgery: a prospective study. Head Neck 23 (2001) 447-455
16. Piccart M., Dor P., and Klastersky J. Antimicrobial prophylaxis of infections in head and neck cancer surgery. Scand J Infect Dis 39 (1983) 92-96
17. Plowman R., Graves N., Griffin M.A., Roberst J.A., Swan A.V., Coockson B., and Taylor L. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialities of a district general hospital in England and the national burden imposed. J Hosp Infect 47 (2001) 198-209
18. Raphael R., Yves D., Giselle C., Magali M., and Odile M.C. Cancer treatment at home or in the hospital: what are the costs for French public health insurance? Findings of a comprehensive-cancer center. Health Policy 72 (2005) 141-148
19. Ribeiro K.C.B., Kowalsky L.P., and Latorre M.R.D.O. Perioperative complications, comorbidities and survival in oral and oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 12 (2003) 219-228
20. Rosenthal V.D., Guzman S., Migone O., and Safdar N. The attributable cost and length of stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis. Am J Infect Control 33 (2005) 157-161
21. Rubin R.J., Harrington C.A., Poon A., Dietrich K., Greene J.A., and Moiduddin A. The economic impact of Staphylococcus aureus infection in New York hospitals. Emerg Infect Dis 5 (1999) 9-17
22. Snyderman C.H., Kachman K., Molseed L., Wagner R., D'Amico F., Bumpous J., and Rueger R. Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope 109 (1999) 915-921
23. Société Française d'Anesthésie-Réanimation. Recommandations pour la pratique de l'antibioprophylaxie en chirurgie. Actualisation 1999. Coordonateur Pr C Martin Presse Med 2001; 30: 794-802.
24. Tibi-Levy Y., de Pouvourville G., Rozenholc Y., Goursot G., Clergue F., Délémontey B., Feiss P., Laxenaire M.C., Marty J., and Béresniak A. Evaluation of benefits related to reduced length of stays in postanesthesia care units. Int J Technol Assess Health Care 14 (1998) 172-179
25. Vossing M., and Eckel H.E. Nosocomial infections in head and neck surgery. HNO 44 (1996) 61-67 [in German]
26. Watters K., O'Dwyer T.P., and Rowley J. Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences?. J Laryngol Otol 118 (2004) 694-699
27. Weber R.S., Hankins P., Rosenbaum B., and Raad I. Nonwound infections following head and neck oncologic surgery. Laryngoscope 103 (1993) 22-27
28. Wenisch C., Wergartner T., Saisler M., and Patruta S. Effect of preoperative prophylaxis with filgrastim in cancer neck dissection (Abstract meeting). J Antimicrob Chemother 44 Suppl. A (1999) S161